Alpha Cognition Inc ACOG 深 滬
已收盤 08-07 16:00:00 美东时间
9.13
+0.460
+5.31%
華盛通- 最 高9.21
- 今 開8.80
- 成交量 3.11万股
- 最 低 8.60
- 昨 收 8.67
- 總市值 1.99亿
- 52周最高 9.9999
- 市盈率 靜 --
- 換手率 0.14%
- 52周最低 4.50
- 委 比 98.97%
- 總股本 2177.41万
- 歷史最高 11.54
- 量 比 0.41
- 振 幅 7.04%
- 歷史最低 3.75
- 每 手 1
- 風險率 1.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Alpha Cognition’s RESOLVE Study: Fresh Real‑World Data on Zunveyl in Alzheimer’s Care
Alpha Cognition Inc ($ACOG) announced an update on their ongoing clinical study...
07-21 00:30
美股大行评级 | 潜在涨幅98.68%！DA Davidson上调Almonty Industries目标价至33美元，维持"买入"评级
今日重点评级关注：DA Davidson：维持Almonty Industries"买入"评级，目标价从25美元升至33美元；Stifel：维持Nurix Therapeutics"买入"评级，目标价从34美元升至40美元
07-13 10:13
Raymond James Initiates Coverage On Alpha Cognition with Outperform Rating, Announces Price Target of $20
Raymond James analyst Ryan Deschner initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Outperform rating and announces Price Target of $20.
07-10 18:53
Alpha Cognition Appoints Robert Wills As Board Chairman, Succeeding Len Mertz
Alpha Cognition Inc. (Nasdaq: ACOG) ("Alpha Cognition", or the "Company"), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeedin...
06-23 20:35
Alpha Cognition Reports Top-Line Results From BEACON Real-World Study Of ZUNVEYL
Providers reported cognitive improvement in 92% of patients following initiation of ZUNVEYLProviders reported improvement in neuropsychiatric symptoms in 93% of patients after initiation of ZUNVEYLProviders
06-09 20:05
美股大行评级 | Susquehanna上调美光目标价从600美元升至1750美元；戴尔、MongoDB、网泰信息存储、Nextpower、Okta等获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Aclarion"买入"评级，目标价从7美元升至7.5美元；Susquehanna：维持美光科技"积极"评级，目标价从600美元升至1750美元
06-01 14:11
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers INVO Fertility (NASDAQ:IVF) shares increased by 33.0% to $2.5 during F...
05-30 05:05
Maxim Group Initiates Coverage On Alpha Cognition with Buy Rating, Announces Price Target of $12
Maxim Group analyst Naz Rahman initiates coverage on Alpha Cognition (NASDAQ:ACOG) with a Buy rating and announces Price Target of $12.
05-29 21:47
电话会总结 ｜ Alpha Cognition(ACOG)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Alpha Cognition业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2026年第一季度实现净产品收入350万美元，较2025年第四季度的250万美元环比增长40%。与2025年第一季度的34.7万美元相比，同比大幅增长，但需注意2025年第一季度仅包含3月最后两周的商业化收入。 **盈利状况：** 净亏损650万美元，合每股亏损0.30美元，较2025年第一季度净亏损170万美元（每股亏损0.11美元）同比扩大。 **运营费用：** 总运营费用（含收入成本）约1160万美元，较2025年第四季度的1070
05-15 12:08
